Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients

Published:2020-12 Issue: Volume:42 Page:e30-e34
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Watts Gerald F.,Catapano Alberico L.,Masana Luis,Zambon Alberto,Pirillo Angela,Tokgözoğlu Lale

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference40 articles.

1. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

2. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II;Gitt;Atherosclerosis,2017

3. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2019

4. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease - executive summarycomplete appendix to guidelines;Jellinger;Endocr Pract,2017

5. Extreme-risk category: high prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55mg/dL;Rallidis;Atherosclerosis,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LDL-Cholesterol-Lowering Effects of a Dietary Supplement Containing Onion and Garlic Extract Used in Healthy Volunteers;Nutrients;2024-08-22

2. Comparative effectiveness of different methods of prescribing rosuvastatin and ezetimibe in combination with PCSK9 inhibitors;Medical Herald of the South of Russia;2024-06-15

3. Electrocontractile remodeling of isolated cardiomyocytes induced during early-stage hypercholesterolemia;Journal of Bioenergetics and Biomembranes;2024-06-13

4. Exploring sex variations in the incidence of cardiovascular events: a counterfactual decomposition analysis;European Journal of Public Health;2024-01-02

5. The Role of Gut Dysbiosis in Cardiovascular Diseases;Advances in Biochemistry in Health and Disease;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3